Teva Pharmaceutical Industries Ltd. ADR (TEVA) News
Filter TEVA News Items
TEVA News Results
|Loading, please wait...|
TEVA News Highlights
- 500 - Internal server error
- Over the past 27 days, the trend for TEVA's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
- API, TEL and MG are the most mentioned tickers in articles about TEVA.
Latest TEVA News From Around the Web
Below are the latest news stories about Teva Pharmaceutical Industries Ltd that investors may wish to consider to help them evaluate TEVA as an investment opportunity.
Additionally, don't overlook great companies just because they don't have a triple-digit share price like many of these fastest-growing tech and healthcare stocks. It could be argued that some of the best values today can be found boasting single-digit share prices. Arguably the most attractive investment opportunity under $10 today is U.S. marijuana stock Jushi Holdings (OTC: JUSHF).
Global Respiratory Antiviral Drugs Market Comprehensive Analysis of Industry Share, Size, Growth Outlook up to 2027||Genentech, Inc., Nabriva Therapeutics plc, Merck Sharp & Dohme Corp., Teva Pharmaceutical Industries Ltd., Novartis AG
An international Respiratory Antiviral Drugs market report provides in-depth evaluation on a global and regional level. The report study offers historic facts and forecasted data. The document consists of a complete evaluation of factors impacting the growth of the market.
TEL AVIV, Israel & PARSIPPANY, N.J., July 21, 2021--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced changes to its leadership team. Brendan O’Grady, Executive Vice President, North America Commercial, will leave Teva to pursue a career opportunity outside of the pharmaceutical industry, and Sven Dethlefs, who currently serves as Teva’s Executive Vice President, Global Marketing and Portfolio and International Markets Commercial has been appointed the new head of North A
With a $26 billion nationwide settlement in sight over claims that the three largest U.S. drug distributors and Johnson & Johnson helped fuel a nationwide opioid epidemic, state and local governments will soon turn their attention to pharmacies and a handful of drugmakers. U.S. state attorneys general are expected to unveil a settlement proposal this week with distributors McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp contributing a combined $21 billion, while Johnson & Johnson would pay $5 billion.
Ribociclib Succinate Market Size by Top Companies, Trends by Types and Application, Forecast to 2027 | Teva Pharmaceutical Industries, Chunghwa Chemical Synthesis & Biotech, Zhejiang Hengtengfu
The report titled Global Ribociclib Succinate Market is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Ribociclib Succinate market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, 
Insights on the Losartan Global Market to 2026 - Featuring Pfizer, Teva Pharmaceutical Industries and Sanofi Among Others
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Global Losartan Market, By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application, By End-User, By Region, Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com''s offering. The Global Losartan Market was valued at $4.73 billion in 2020 and is expected to grow at a formidable rate of 7.81% during the forecast period. The Global Losartan Market is driven by the growing prevalence of hypertension, stroke and diabetic nephropathy across the world. Losartan is a medication that is used to treat high blood pressure. Furthermore, losartan is widely used in slowing down long-term kidney damage due...
In this article you are going to find out whether hedge funds think Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus […]
Torg-Winchester Syndrome Market 2021 COVID-19 Impact Analysis, Key Players, Segmentation, Application And Forecast By 2028 - F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Astellas Pharma Inc, Novartis AG, and AstraZeneca
By understanding the trends in consumer and supply chain dynamics, Global Torg-Winchester Syndrome Market report helps to draw the strategies about sales, marketing, and promotion. Expert solutions and proficient capabilities have been utilized to generate this market research report. The
Healthcare Nanotechnology (Nanomedicine) Market 2021 to Witness Huge Growth by 2027| Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker
A recent market research report added to repository of MarketInsightsReports is an in-depth analysis of Global Healthcare Nanotechnology (Nanomedicine) Market. On the basis of historic growth analysis and current scenario of Healthcare Nanotechnology (Nanomedicine) market place, the report intends to
Eluxadoline API Market Outlook, Development Factors, Latest Opportunities and Forecast 2027 | Tecoland, FCDA, Teva Pharmaceutical Industries
The report titled Global Eluxadoline API Market is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Eluxadoline API market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints,